Bluetongue is a disease of ruminants which reached Denmark in 2007. We present a process-based stochastic simulation model of vector-borne diseases, where host animals are not confined to a central geographic farm coordinate, but can be distributed onto pasture areas. Furthermore vectors fly freely and display search behavior to locate areas with hosts. We also include wind spread of vectors, h...

A light-trap survey was undertaken of the species composition, seasonal abundance and parity of Culicoides at Roma, Lesotho, to establish whether the likely vectors for bluetongue and African horse sickness occur in this area as well as the chance of transmission. A total of 34 catches was made between 21 September 1985 and 24 September 1986; 32,819 Culicoides were caught belonging to 19 specie...

The concentration of double-stranded RNA within the bluetongue virus core renders the genome segments liquid crystalline. Powder diffraction rings confirm this local ordering with a 30 A separation between strands. Determination of the structure of the bluetongue virus core serotype 10 and comparison with that of serotype 1 reveals most of the genomic double-stranded RNA, packaged as well-order...

The presence of bluetongue virus (BTV) in indigenous goats from the Karamoja region of northern Uganda was investigated. A total of 300 goats were sampled (serum and whole blood) from five districts within the Karamoja region. The samples were analysed for the presence of bluetongue (BT) antibodies using a commercial Enzyme-linked immunosorbent assay (ELISA) and for the presence of BTV viral RN...

Bluetongue (BT) is a viral disease of ruminants transmitted by Culicoides biting midges and has the ability to spread rapidly over large distances. The disease occurs almost worldwide between latitudes approximately 35˚ S and 50˚ N. Among the numerous diseases of ruminants, BT has gained considerable importance in recent years as one of the best examples of the effects of climate change on dise...

This publication was also sponsored by the European Commission (Health and Consumer Protection Directorate-General), the Veterinary and Agrochemical Research Centre, Brussels The Institute of Tropical Medicine, Antwerp the Notre-Dame de la Paix University Faculties of Namur, the Federal Public Service of Public Health, Food Chain Security and Environment, Brussels and the Federal Agency for the...

1496 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 9, September 2008 The precision of subtyping assays is a matter of importance and debate for epidemiologic and, recently, forensic investigations. Strain identity is commonly used to infer a common source even when spatial and temporal data are not congruent. Moreover, the defi nition of a strain is somewhat unclear and relies o...

The article reviews the history, present status and the future of BT vaccines in Europe. So far, an attenuated (modified live viruses, MLV) and inactivated virus vaccines against BT were developed and used in the field. Moreover, the virus-like particles (VLPs) produced from recombinant baculovirus, and live recombinant vaccinia or canarypox virus-vectored vaccines were tested in the laboratory...

Introduction Bluetongue virus (BTV) first emerged in the European Union (EU) in 2006, peaking at 45,000 cases in 2008. The EU spent million of euros in 2008 and 2009 on eradicating and monitoring programs, co-financed with member states. The number of cases in 2009 was 1118, with only 120 reported across the EU so far last year. Vaccination has proven itself as the most effective tool to contro...